AFP Levels: What Does a Rapid Drop Mean for Tumor Recurrence?

The fetal protein level was 97, and after four days, the test result was less than 3. What is the likelihood of tumor recurrence?

My daughter had hepatoblastoma with an alpha-fetoprotein (AFP) level peaking at 1.3 million.
After chemotherapy and surgery, her levels were normal for five months.
However, last week, her AFP level rose to 97, and upon retesting, it was still 90 (from the same blood sample).
Just four days later, serum testing showed a level of 5, and two nuclear medicine tests indicated levels less than 3.

What could be happening? The half-life of AFP is typically 5 to 7 days, so how could it drop from 97 to less than 3 in such a short time? The oncologist mentioned that sometimes small tumors may secrete AFP inconsistently, but the hepatobiliary surgeon indicated that hepatoblastoma is usually very sensitive to recurrence, and AFP levels typically do not decrease so dramatically in such a short period.

What is the likelihood of recurrence? A CT scan showed no tumors, but a PET scan indicated a slight issue with the kidneys, which doesn’t seem to correlate with the MRI report that hasn’t been released yet.
I’m concerned that we may not be able to detect anything.
Please, I would appreciate any insights.
My child is only 1 year and 8 months old, and I am extremely worried.
What does the drop from AFP 97 to less than 3 in just four days signify? Currently, she is not undergoing chemotherapy.

ABC, 0~9 year old female. Ask Date: 2008/12/27

Dr. Chen Qifeng reply Gastroenterology and Hepatology

Hello, basically any test can have errors (testing variability), and each test can show slight fluctuations because normal values for any parameter are a range rather than absolute values.
Additionally, EIA (Enzyme Immunoassay) and RIA (Radioimmunoassay) cannot be directly compared.
Physicians typically do not make decisions solely based on blood tests; they also consider results from other examinations.
As for whether there is a recurrence at this time, it can be assessed after monitoring AFP levels over a period.
Best wishes, Dr.
Chi-Feng Chen, Taoyuan Hospital, Department of Health.

Reply Date: 2008/12/27

More Info

Understanding the fluctuations in alpha-fetoprotein (AFP) levels, especially in the context of hepatoblastoma, is crucial for assessing tumor recurrence and overall patient prognosis. In your daughter's case, the significant drop in AFP levels from 97 to less than 3 within just four days raises several important considerations.

Firstly, AFP is a protein that is typically produced by the liver and yolk sac of a developing fetus. In adults, elevated AFP levels can indicate liver disease or certain types of cancer, particularly hepatocellular carcinoma or germ cell tumors. In pediatric cases, such as hepatoblastoma, AFP is often used as a tumor marker to monitor disease progression and response to treatment.

The half-life of AFP is indeed around 5 to 7 days, which means that significant changes in AFP levels can occur over a relatively short period, especially in the context of active disease. However, the rapid decrease you observed—from 97 to less than 3—within four days is quite unusual and warrants a closer examination.

1. Possible Explanations for the Fluctuation:
- Laboratory Variability: One possibility is laboratory error or variability in the testing process. It’s essential to ensure that the tests are conducted under the same conditions and that the same methodology is used for accurate comparison.

- Tumor Activity: As your oncologist mentioned, small tumors may intermittently secrete AFP, leading to fluctuating levels. This could explain why AFP levels might rise and fall, depending on the tumor's activity or metabolic state at the time of testing.

- Response to Treatment: If your daughter underwent recent treatment, the drop in AFP could indicate a positive response to therapy, suggesting that the tumor burden may have decreased significantly.

2. Assessing Recurrence Risk:
- The risk of recurrence in hepatoblastoma is often assessed through a combination of imaging studies (like CT and MRI) and tumor markers like AFP. A significant drop in AFP, especially after a period of elevated levels, can be a good sign, but it should be interpreted cautiously.

- The fact that imaging studies (CT and PET scans) did not reveal any tumors is encouraging. However, it is essential to continue monitoring AFP levels and conduct regular imaging to ensure that any potential recurrence is detected early.

3. Next Steps:
- Continued Monitoring: Regular follow-up appointments with your daughter's healthcare team are crucial. They may recommend repeating AFP tests and imaging studies to track any changes over time.

- Consultation with Specialists: If there is uncertainty regarding the interpretation of AFP levels or imaging results, consider seeking a second opinion from a pediatric oncologist or a hepatologist who specializes in liver tumors in children.

4. Emotional Support: It’s understandable to feel anxious about your daughter’s health, especially given her young age. Engaging with support groups or counseling can provide emotional support during this challenging time.

In conclusion, while the rapid drop in AFP levels is promising, it is essential to continue monitoring and follow up with your healthcare team for a comprehensive assessment of your daughter's condition. Regular communication with her medical providers will help clarify any uncertainties and guide the next steps in her care.

Similar Q&A

Can a 1.5 cm Liver Tumor Cause AFP Levels to Exceed 400?

Hello Dr. Tsai, My father was first diagnosed with a liver tumor in 2006 and underwent radiofrequency ablation. For the following years, he was monitored and everything was fine. However, in 2015, his alpha-fetoprotein (AFP) levels increased, and upon further investigation, a s...

Dr. Cai Anshun reply Gastroenterology and Hepatology
Hello: It is not possible to estimate cancer markers based on tumor size. If it cannot be determined whether there is metastasis, we should first address the currently obvious targets and observe how the fetal protein responds. X-rays may have some blind spots, or the tumor could...

Managing Liver Tumor Treatment: Patient Guidance and Medication Options

My father has undergone multiple treatments for liver tumors, including several embolizations and radiofrequency ablations. During a follow-up appointment, his alpha-fetoprotein (AFP) level was still 21.9. When I asked the attending physician, they were unsure of the reason. I wo...

Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, after multiple treatments for liver cancer, the AFP level remains high. It is recommended to compare the current AFP value with previous values. Common causes of elevated AFP include chronic hepatitis, liver cirrhosis, and liver cancer. Elevated AFP can still occur in case...

Understanding Elevated Alpha-Fetoprotein Levels: What You Need to Know

Hello Dr. Chen, My family member is a carrier of hepatitis B and has not been monitored for three years. This month, the GOT and GPT levels are normal, but the AFP level is 360 ng/ml. Is this situation concerning? Will the AFP level decrease? Thank you for your response, Dr. Ch...

Dr. Chen Sirong reply Oncology
Ms. Hu / 30 years old / Female Hello~ 1. Is this situation not good? A: This index raises suspicion for cancer. An ultrasound is necessary for initial assessment, followed by further imaging studies such as a CT scan, angiography, or liver MRI as directed by the physician for...

Understanding Recurrence in Breast Cancer: Treatment Options and Prognosis

Hello Doctor: In November 2000, I was diagnosed with stage I breast cancer (T1N0M0) and underwent breast-conserving surgery followed by four cycles of chemotherapy (Adriamycin) and 30 sessions of radiation therapy. At that time, the pathology report indicated: nuclear grade 2, ER...

Dr. Chen Junyi reply Oncology
1. It is likely related to issues with the pathological examination at that time, or the degeneration of cancer cells. 2. As for the subsequent treatment and prognosis, it may depend on the patient's response to the medication. Thank you.